ASO Author Reflections: Carcinoembryonic Antigen as a Predictor of Failure to Reach Surgery in Patients with Borderline Resectable Pancreatic Cancer Undergoing Neoadjuvant Therapy. [PDF]
Jacover A, Pencovich N.
europepmc +1 more source
Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report [PDF]
Callebout, Eduard+7 more
core +2 more sources
Carcinoembryonic Antigen and Prognosis in Patients with Colon Cancer
Paul Lo Gerfo, Frederic P. Herter
openalex +2 more sources
(Washington University Case Conference). Colorectal carcinoma and carcinoembryonic antigen (CEA). [PDF]
J H Ladenson+3 more
openalex +1 more source
Emerging Biosensor Technologies for Stroke Biomarker Detection: A Comprehensive Overview
ABSTRACT Stroke remains a leading cause of morbidity and mortality worldwide, necessitating the development of rapid and reliable diagnostic tools for early detection and management. This manuscript presents an overview of innovative biosensors designed for the detection of key stroke biomarkers, including N‐terminal pro B‐type natriuretic peptide (NT ...
Ghazal Koohkansaadi+3 more
wiley +1 more source
A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies [PDF]
Tomohiro Yoshimoto+8 more
openalex +1 more source
The top row shows key drivers‐KRAS, c‐Myc and HIF‐1a‐alongside gut and tumor microbiota, all converging on glutamine metabolism in PDAC. At the center, glutamine handling is depicted as the linchpin of tumor growth, biosynthesis and immune modulation. The green panel lists major intervention strategies: DON‐loaded nanoparticles, prodrugs (DRP‐104/JHU ...
Min Su+4 more
wiley +1 more source
Influence of age and sex on the diagnostic accuracy of pleural fluid carcinoembryonic antigen for malignant pleural effusion: a <i>post hoc</i> analysis. [PDF]
Yang DN+14 more
europepmc +1 more source
Carcinoembryonic antigen in primary carcinoid tumors of the lung [PDF]
George A. Bishopric, Nelson G. Ordóǹez
openalex +1 more source
Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun+10 more
wiley +1 more source